Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study aims to evaluate the efficacy and safety of DCV plus sofosbuvir (SOF) with or without ribavirin (RBV) for treatment of Egyptian participants infected with HCV GT4.
Epistemonikos ID: 38447e7110a9575927dbd28b8fa1be09f3f455c5
First added on: May 07, 2024